-
Tytuł:
-
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
-
Autorzy:
-
Bedognetti D; Sidra Medicine, Doha, Qatar.
Ceccarelli M; AbbVie, Redwood City, CA, USA.
Galluzzi L; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, New York, NY, USA.; Université Paris Descartes/Paris V, Paris, France.
Lu R; AbbVie, Redwood City, CA, USA.
Palucka K; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Samayoa J; AbbVie, Redwood City, CA, USA.
Spranger S; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MT, USA.
Warren S; NanoString Technologies, Inc, Seattle, WA, USA.
Wong KK; Perlmutter Cancer Center, New York Langone Health, New York, NY, USA.
Ziv E; University of California, San Francisco, CA, USA.
Chowell D; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Coussens LM; Oregon Health & Science University, Portland, OR, USA.
De Carvalho DD; Department of Medical Biophysics, Princess Margaret Cancer Centre University Health Network, University of Toronto, Toronto, Canada.
DeNardo DG; Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Galon J; INSERM, Laboratory of Integrative Cancer Immunology, Equipe Labellisée Ligue Contre le Cancer, Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers, F-75006, Paris, France.
Kaufman HL; Massachusetts General Hospital, Boston, MA, USA and Replimune, Inc, Woburn, MA, USA.
Kirchhoff T; Perlmutter Comprehensive Cancer Center, New York University School of Medicine, New York University Langone Health New York, New York, NY, USA.
Lotze MT; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Luke JJ; University of Chicago, Chicago, IL, USA.
Minn AJ; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA.
Politi K; Yale School of Medicine, New Haven, CT, USA.
Shultz LD; The Jackson Laboratory Cancer Center, Bar Harbor, ME, USA.
Simon R; R. Simon Consulting, Potomac, MD, USA.
Thórsson V; Institute for Systems Biology, Seattle, WA, USA.
Weidhaas JB; University of California, Los Angeles, Los Angeles, CA, USA.
Ascierto ML; MedImmune, Gaithersberg, MD, USA.
Ascierto PA; Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy.
Barnes JM; AbbVie, Redwood City, CA, USA.
Barsan V; Stanford University, Stanford, CA, USA.
Bommareddy PK; Rutgers University, New Brunswick, NJ, USA.
Bot A; Kite, a Gilead Company, Santa Monica, CA, USA.
Church SE; NanoString Technologies, Inc, Seattle, WA, USA.
Ciliberto G; IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy.
De Maria A; Università degli Studi di Genova and Ospedale Policlinico San Martino IRCCS, Genoa, Italy.
Draganov D; Calidi Biotherapeutics, San Diego, CA, USA.
Ho WS; Department of Neurosurgery, Division of Pediatric Neurosurgery, Primary Children's Hospital, University of Utah, Salt Lake City, UT, USA.
McGee HM; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Monette A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Murphy JF; Caprion Biosciences Inc, Montreal, QC, Canada.
Nisticò P; IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy.
Park W; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Patel M; AbbVie, Redwood City, CA, USA.
Quigley M; Bristol-Myers Squibb Company, Redwood City, CA, USA.
Radvanyi L; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Raftopoulos H; Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USA.
Rudqvist NP; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
Snyder A; Merck & Co, Kenilworth, NJ, USA.
Sweis RF; University of Chicago, Chicago, IL, USA.
Valpione S; CRUK Manchester Institute and The Christie NHS Foundation Trust, The University of Manchester, Manchester, UK.
Zappasodi R; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
Disis ML; University of Washington, Seattle, WA, USA.
Fox BA; Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, OR, USA.
Cesano A; NanoString Technologies, Inc, Seattle, WA, USA.
Marincola FM; Refuge Biotechnologies Inc, 1505 Adams Drive, Suite D, Menlo Park, CA, 94025, USA. .
-
Corporate Authors:
-
Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
-
Źródło:
-
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Jul 04; Vol. 7 (1), pp. 167. Date of Electronic Publication: 2019 Jul 04.
-
Typ publikacji:
-
Published Erratum
-
Język:
-
English
-
Imprint Name(s):
-
Publication: 2020- : London, United Kingdom : BMJ Publishing Group Ltd.
Original Publication: London : BioMed Central, 2013-
-
References:
-
J Immunother Cancer. 2019 May 22;7(1):131. (PMID: 31113486)
-
Grant Information:
-
R01 CA238998 United States CA NCI NIH HHS; UL1 TR001863 United States TR NCATS NIH HHS
-
Entry Date(s):
-
Date Created: 20190706 Latest Revision: 20210316
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC6610889
-
DOI:
-
10.1186/s40425-019-0640-y
-
PMID:
-
31272507
Following publication of the original article [1], the author reported that an author name, Roberta Zappasodi, was missed in the authorship list.
Erratum for: J Immunother Cancer. 2019 May 22;7(1):131. (PMID: 31113486)
